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It is most regrettable that tonight's fine and factual presentation by Dr.
Peyton Rous will not be made available to the readers of the Journal of Investi-
gative Dermatology. I would however like to present a few of my own specula-
tions on experimental dermatologic approaches to the cancer problem.
There is surely no need for me to explain or justify to this audience the der-
matologist's ancient, keen and continuing interest in the problems of cancer and
carcinogenesis. Statistics on the incidence of cancer tell why dermatologists
are always necessarily cancer specialists—for, as you have heard, skin cancer
may be as common as the sum of cancers of all other organs combined. The
history of the study of cancer tells why dermatologic studies have always been
in the forefront of advancing knowledge on the causes of cancer. The first
recognized causes were those which produced cancer of the skin, e.g., the skin
cancers produced by derivatives of burning coal and wood in chimney sweeps,
as described by Sir Percival Pott; the skin cancers produced by oil in mule-
spinners; the skin cancers produced by arsenic, by tars, by light, by x-rays, by
thermal burns—these are all among the earliest examples of cancer-causes
recognized and studied by the clinician. And if one turns from the clinic to
the experimental laboratory one finds that the earliest studies in carcinogenic
compounds and forces were those which dealt with the skin; first the studies of
the Japanese and those of Br. Bloch and Dreyfoos on cutaneous tar cancers in
mice; then the fractional distillation of tars and the recognition and isolation of
the carcinogenic tar fractions by Bloch and co-workers; then the discovery by
organic chemists of the benzpyrenes, anthracene and methylcholanthrene and
their derivatives as powerful simple chemical skin carcinogens; and the works
of dermatologists far too numerous to mention, dealing with such subjects as
experimental cutaneous cancers due to tars, scarlet red, to photosensitizing
agents, to x-rays, burns, etc. And here too, one must not forget the dermato-
logic studies of precanceroses, such as Bowen's disease, senile keratomas and
erythroplasia and leukoplakias and certain pigmented moles; nor the fact that
observations of growths on the skin were the basis for the epoch-making dis-
coveries of the infectious virus carcinomas by Peyton Rous and the verrucous
preepitheliomas and epitheliomas caused by Richard Shope's papillorna virus.
The preceding is but a very inadequate and fragmentary listing of the veri-
tably legion examples of how both cutaneous studies and studies by dermatolo-
gists have always been and must ever be maj or contributors to the progress of
knowledge on cancer.
And against this background of an illustrious dermatologic past in cancer
research perhaps you will permit me to attempt to speculate on a possibly fruitful
dermatologic and immunologic approach to cancer studies in the future.
The following are among the facts you know and have heard reviewed tonight:
First: When chemical carcinogens are applied to the tissues of an appropriate
83
84 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
susceptible experimental animal, no matter how powerful the agent, no matter
how susceptible the animal, no matter how concentrated the solution, in short,
no matter how intense the application of the noxa—the time it takes for the
first truly malignant changes to appear cannot be shortened beyond a certain
irreducible minimum.
There is, in other words, the equivalent of an incubation period required for
the development of the specific malignant tissue—reaction to the chemical.
Second: Certain species, certain strains of animals, certain families and certain
individuals are much more susceptible than are others to the carcinogenic action
of a given chemical. And some species, strains or individuals do not develop
cancer, no matter how intense the noxa. There is, in other words, an apparently
gene-determined innate immunity or susceptibility to the specific action of the
chemical. For example, no chemical carcinogen has as yet been demonstrated
to be capable of producing skin cancer in the guinea pig.
Third: When one applies a chemical carcinogen to the tissues of an appropriate
susceptible animal, no matter how even and equal and general the exposure,
only certain circumscribed sites develop cancer. For example, if one tars the
entire skin of the back of a mouse only certain spots begin to develop carcinomas,
first one spot, and then another—but never the entire skin surface, despite the
apparently general and equal distribution of the carcinogen. There is, in other
words, evidence of localized, fixed areas of particular susceptibility to the specific
action to the chemical.
Fourth: The specific reaction to the chemical carcinogen apparently takes
place first and principally in the epithelium. In other words, in the skin, the
site of the earliest, pri'ncipal and characteristic response to the specific action of
the chemical is in the epidermis.
It would only unnecessarily labor the points I am trying to make, were I to
add to these four facts the discussion of such matters as the long periods of imp-
munity, or latency, which are found in some skin cancers (I have seen 15 to 20
years elapse before the first clinical manifestation in some skin cancers due to
arsenic); or the observation that many substances, such as arsenicals and tar
derivatives and certain dyes are at the same time powerful chemical carcinogens
and producers of eczematous allergic hypersensitivity; and many other pertinent
findings which spring to mind. I feel that you all are 'way ahead of me and see
what I am getting at—namely the many and perhaps basic resemblances between
the phenomena of chemical carcino genesis and eczematous, allergic sensitization to
simple chemicals, as seen in contact-type allergic dermatitis. Both of these
biologic morbid happenings have in common the incubation periods; the gene-
determined innate susceptibility or immunity; and the sites of principal charac-
teristic reaction in the epithelium—and many other resemblances.
Perhaps a quotation from a chapter entitled "The Future of Allergy" which
appeared in a text-book published in 1940 will serve best to frame the hypothesis
about which I am speculating (Sulzberger, Marion B.—Dermatologic Allergy,
pp. 428—429):
"There are very many other urgent problems which may be connected with
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the concept of epithelial allergy, and not the least of these is the problem of
carcinogenesis and the possible relationship between epithelial sensitization and
the effects of carcinogenic agents.
"We know many carcinogenic substances are capable also of specifically
sensitizing the epithelium of the skin. The best examples are perhaps the coal-
tar derivatives and arsenic.
"Is it possible that the epithelium of certain areas and sites, having been sen-
sitized by previous exposure to arsenic or to coal-tar derivatives or to other
carcinogenic compounds—or even to sterol compounds and other carcinogens of
autochtonous origin (estrogens, male sex-hormones, bile constituents, Vitamin D.,
etc.)—may constantly or intermittently be reacting to the normal minute exposures
to the sensitizing agents?
"Experiments in the production of cancer have shown that localized epithelial
reactions can be subliminal, i.e. not clinically manifest; but may nevertheless
represent a type of irritation which, when often repeated throughout longer periods
of time, eventually leads to cancer. And, in view of what we have seen in other
forms of allergy (e.g. drug allergy and fixed eruptions—Lecture XIII), is it not
conceivable that in one individual a site in the mammary gland; in another, a
site in the liver, or in the skin, or in any other organ subject to cancer, may be-
come allergically sensitive to some otherwise innocuous circulating carcinogenic
allergen? And that in this individual and in this allergic site only, the constant
or repeated subliminal allergic reactions finally produce the malignant epithelial
change?
"The actual value of such an hypothesis is in large measure dependent upon
the ease with which it may be subjected to experimental substantiation or dis-
proof. And I wish to emphasize that the concept of eczematous epithelial
allergy leads to the possibility of experimental study of local responses to hormonal
effects and local responses to carcinogenic agents and their possible connection
with specifl allergic changes in epithelial capacity to react.
"There is already some dermatologic support to this hypothesis. For example,
the epithelial follicular stimulation, which leads to acne vulgaris, is almost surely
due, either directly, or indirectly, to the action of estro genie substances or sterol
derivatives of male or female sex-hormones; or rather to an imbalance or dispropor-
tion in the ratios and relationships of those compounds and their local and
systemic effects. (See Sulzberger, Rostenberg and Sher (20) also Figs. 23,45 and
Lecture XIII). And it may be of some significance to note that many known
sensitizers of eczematogenous nature—such as arsenic, coal tar derivatives,
petroleum products, dyes and their intermediates, etc.—are usually capable of
producing, not only skin cancers, but also acneform dermatoses, pigmentations
and depigmeritations, hyperkeratoses, dyskeratoses, papillomas, warty growths,
and all the stages between simple allergic epidermal reactions (eczematous dermatitis)
and true cancer. The examples I have just outlined by no means exhaust the
possible relationships between allergy and cancer."
Since this was written, still more experimental support has appeared for the
hypothesis mentioned. Most recently E. V. Cowdry (J. A. M. A. 135: 408,
86 TRE JOURNAL OF INVESTIGATIVE DERMATOLOGY
(Oct. 18, 1947)) quoting an article by Simpson and Cramer (Sensitization, of the
Skin by Carcinogenically Inactive Methyicholanthrene for Subsequent Carci-
nogenesis. Cancer Research: #5 —5 to 10, 1944), stated that methylcholan-
threne, a carcinogen if embodied in lanolin, does not produce carcinomas, no
matter how long a time it is applied. However, if, after a period of rest, methyl-
cholanthrene—the same substance in benzene—was applied, carcinomas ap-
peared very promptly without the incubation period. Cowdry concluded there-
f ore that "methylcholanthrene in lanolin sensitizes the epidermis to the same
carcinogen in benzene". Thus his conclusion is identical with that of the
hypothesis outlined previously.
As I have stated before, any theory or hypothesis about carcinogenesis is
valuable largely to that degree to which it can be put to experimental or clinical
test. And I submit that the theory of the relationship between specific immuno-
logic sensitization and the mechanisms of carcinogenesis is readily and easily
accessible to experimental testing and has not yet received its due share of
careful investigation.
Dermatologists, immunologists and other laboratory workers might find
their joint efforts well repaid were they to form teams for investigating such
problems as: whether chemical carcinogens produce specific immunologic changes
in the skins, sera or other tissues or fluids of experimental animals; whether the
animal is truly, specifically sensitized to chemical carcinogens and evidences a
specific susceptibility to carcinogenesis only by that same compound; that is,
whether the preceding application of one carcinogen such as methylcholanthrene
sensitizes to subsequent application of only methyicholantherene, or whether
the skin has become non-specifically sensitized to other carcinogenic noxae as
well; why the guinea pig's skin distinguishes itself by being highly immune to
carcinogenesis by external exposure to simple chemicals while it is—with the
exception of the human skin—the most susceptible to allergic sensitization to
the simple chemicals which act as common eczematogenous contact allergens;
and why, contrariwise, the mouse, rat and rabbit are susceptible to chemical
carcinogenesis of the skin but apparently immune to eczematogenous sensitiza-
tion by contact allergens; and whether this reciprocally exclusive relationship
of the two susceptibilities indicates that the tissue which undergoes one form,
e.g., the acute, inflammatory eczematoid reaction of immunologic response, is
thereby protected from the hyperplastic, dyskeratotic and malignant changes;
and whether—provided specific sensitization to foreign substances or one's own
body substances are at the basis of carcinogenesis—immunologic immunization
or neutralization or elimination of causal antigens and allergens may not provide
fruitful approaches to cancer prevention and cancer treatment.
These and many other experimental possibilities come to mind in rich profu-
sion and with almost incalculably important and stimulating implications.
Indeed, this field of research appears to me so promising and so fundamental
that I feel sure that many dermatologists would be glad to devote their greatest
energies to these studies.
About ten years ago I myself applied to a great national cancer foundation
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for a small grant of funds and facilities to tackle some of these problems—but
without success. Despite the enthusiastic approval of each individual scientist
on the Committee, for some, to me obscure, reason my request was officially
refused by the Committee as a whole. Let us hope that the time is here when
adequate cooperation and moneys will be made available for investigations into
the possible relationships between the readily studied specific allergic sensitiza-
tions of particular cutaneous cells and tissues and the genesis of epithelial malig-
nancies and other cancers.
